title: Pharmacological issues in the management of people with mental illness and problems with alcohol and illicit drug misuse.
abstract: BACKGROUND
  While there is plentiful information on the pharmacological management of detoxification from alcohol and on withdrawal from or maintenance of opiates for people with a principal problem of substance misuse or dependency, the pharmacological management of substance misusers presenting with a mental illness can be more complicated. Mental health and substance misuse services tend to be separate, but there is now a drive to increase effective overlap between them by equipping mental health clinicians with the skills and confidence to manage substance misuse disorders in conjunction with major mental illness.
  
  
  OBJECTIVE
  This paper aims to highlight, for a multi-professional readership, some of the prescribing options and precautions to consider when psychotropic medicines are prescribed for treatment of a mental illness in someone who may continue to use illicit substances or alcohol. It also considers interactions with the completely licit substances, nicotine and caffeine. With recent legislation prohibiting smoking in public places people are likely to reduce or stop smoking, which can have a substantial effect on the levels of medication in their blood.
authors: West London Mental Health NHS Trust, Uxbridge Road, Southall, Middlesex UB1 3EU. trudi.hilton@wlmht.nhs.uk
authors: Trudi
authors: T
authors: Hilton
mesh_terms: D000437:Alcoholism / Q000175:diagnosis / Q000534:rehabilitation*; D015897:Comorbidity; D003299:Cooperative Behavior; D017831:Diagnosis, Dual (Psychiatry); D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D013287:Illicit Drugs; D019964:Mood Disorders / Q000175:diagnosis / Q000534:rehabilitation*; D009293:Opioid-Related Disorders / Q000175:diagnosis / Q000534:rehabilitation; D010348:Patient Care Team; D011618:Psychotic Disorders / Q000175:diagnosis / Q000534:rehabilitation*; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use*; D019966:Substance-Related Disorders / Q000175:diagnosis / Q000534:rehabilitation*
chemical_list: D013287:Illicit Drugs; D011619:Psychotropic Drugs